PAR
Click for more information
2.13% 23.0¢ paradigm biopharmaceuticals limited..

re Epiitalissee Clinicaltrials.govthe trial was listed but NOT...

  1. Wwend
    74 Posts.
    lightbulb Created with Sketch. 11
    clock Created with Sketch.
    23/07/21
    06:50
    Post #: 54708308
    re Epiitalis

    see Clinicaltrials.gov
    the trial was listed but NOT evaluated by the FDA
    the sponsor is Vedic Life Sciences.
    the trials were done in nursing homes in Mumbai India.
    PAR Price at posting: $2.01 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢ 		Change
-0.005(2.13%) 		Mkt cap ! $80.45M
Open High Low Value Volume
23.5¢ 24.0¢ 23.0¢ $63.43K 270.4K

Buyers (Bids)

No. Vol. Price($)
10 213534 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 76890 2
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.